GlassScriptPhysician profile
Steve D Phung
NPI 1144212713
$7,045.97
in general payments reported to CMS, 2019-2025
12 companies · $1,139 in 2025
The $1,139 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $19.40 · 2023: $485 · 2024: $5,278 · 2025: $1,139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,655 · Entertainment: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,654.86 |
| Entertainment | $247.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $4,372.82 | 2024 | |
| Bausch & Lomb Americas INC. | $645.48 | 2024-2025 | Infuse, Xiidra, Miebo |
| Glaukos Corporation | $459.23 | 2024-2025 | Photrexa Viscous and Photrexa, Photrexa, Kxl System (Not Refurbished) |
| Coopervision INC. | $450.93 | 2023-2025 | Misight Contact Lens, Onefit Contact Lens |
| Alcon Vision LLC | $341.23 | 2019-2025 | Wavelight Refractive Suite, Tryptyr |
| Optos, INC. | $247.87 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Topcon Healthcare, INC. | $125.01 | 2024 | |
| Sun Pharmaceutical Industries INC. | $125.00 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $121.33 | 2024 | Xdemvy |
| Apellis Pharmaceuticals, INC. | $93.30 | 2024 | Syfovre |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $44.37 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Phung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.